| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |